Compare · PNTM vs TENK
PNTM vs TENK
Side-by-side comparison of Pontem Corporation (PNTM) and TenX Keane Acquisition (TENK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PNTM and TENK operate in Blank Checks (Finance), so they compete in similar markets.
- PNTM carries a market cap of $838.8M.
PNTM
Pontem Corporation
Pontem Corporation does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest PNTM
- SEC Form SC 13G filed by Pontem Corporation
- SEC Form SC 13G/A filed by Pontem Corporation (Amendment)
- SEC Form 15-12G filed by Pontem Corporation
- SEC Form 25-NSE filed by Pontem Corporation
- Pontem Corporation Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination; Redemption Price For The Public Shares Will Be ~$10.32
- Pontem Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Pontem Corporation will redeem its Public Shares and will not consummate an initial business combination
- SEC Form 10-Q filed by Pontem Corporation
- SEC Form 3 filed by new insider Hagen David
- Pontem Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
Latest TENK
- Amendment: SEC Form SC 13D/A filed by TenX Keane Acquisition
- SEC Form 4 filed by Director Dutia Suren G
- SEC Form 4 filed by Director Holubiak Myron Z
- SEC Form 4 filed by Chief Medical Officer Czuczman Myron
- SEC Form 4 filed by Chief Executive Officer Mazur Leonard L
- SEC Form 4 filed by Chief Financial Officer Bartushak Jaime
- SEC Form 4 filed by Director Mcgrath Dennis M
- SEC Form 4 filed by Large owner Citius Pharmaceuticals, Inc.
- SEC Form 4 filed by Director Webb Carol
- SEC Form 3 filed by new insider Dutia Suren G